Juliana Felgueiras

Juliana Felgueiras

Auto-generated profile, based on publicly available information

Juliana Felgueiras

Fardilha’s Lab, Department of Medical Sciences, Institute of Biomedicine—iBiMED, University of Aveiro , Aveiro

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Journal of Zhejiang University-SCIENCE B
Verified
Journal Article
Closed access
PDF file
JFJuliana Felgueiras
Juliana Felgueiras
JSJoana Silva
Joana Silva
Margarida FardilhaMargarida Fardilha
Margarida Fardilha
Prostate cancer (PCa) incidence and mortality have decreased in recent years. Nonetheless, it remains one of the most prevalent cancers in men, being a disquieting cause of men’s death worldwide. Changes in many cell signaling pathways have a predominant role in the onset, development, and progression of the disease. These include prominent pathways involved in the growth, apoptosis, and angiogenesis of the normal prostate gland, such as androgen and estrogen signaling, and other growth factor signaling pathways. Understanding the foundations of PCa is leading to the discovery of key molecules that could be used to improve patient management. The ideal scenario would be to have a panel of molecules, preferably detectable in body fluids, that are specific and sensitive biomarkers for PCa. In the early stages, androgen deprivation is the gold standard therapy. However, as the cancer progresses, it eventually becomes independent of androgens, and hormonal therapy fails. For this reason, androgen-independent PCa is still a major therapeutic challenge. By disrupting specific protein interactions or manipulating the expression of some key molecules, it might be possible to regulate tumor growth and metastasis formation, avoiding the systemic side effects of current therapies. Clinical trials are already underway to assess the efficacy of molecules specially designed to target key proteins or protein interactions. In this review, we address that recent progress made towards understanding PCa development and the molecular pathways underlying this pathology. We also discuss relevant molecular markers for the management of PCa and new therapeutic challenges. 这篇综述系统地阐述了前列腺癌的发生、 发展、 相关分子信号通路以及分子标志物用于前列腺癌的临床诊断和前列腺癌诊治所面临的挑战。 许多分子信号通路通过影响细胞生长、 凋亡、 血管生成等病理生理过程而参与了前列腺癌的起始、 发生和发展。这些研究基础有助于寻找前列腺癌的肿瘤标志物和改进前列腺癌的治疗。 虽然去势治疗是早期前列腺癌治疗的金标准, 但是晚期的激素抵抗型前列腺癌(CRPC)的治疗仍面临着巨大的挑战。所幸的是, 目前研究发现可以通过切断特异的蛋白-蛋白相互作用或者通过调节某些影响肿瘤生长和转移的关键分子来治疗前列腺癌, 能减少传统治疗所带来的副作用; 相关临床研究已开始实施。这些研究进展给前列腺癌的诊治带来了新的曙光。

15 March 2014 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
LKLuís Korrodi‐Gregório
Luís Korrodi‐Gregório
JSJoana Silva
Joana Silva
LSLuís Santos‐Sousa
Luís Santos‐Sousa
MFMaria João Freitas
Maria João Freitas
JFJuliana Felgueiras
Juliana Felgueiras
Margarida FardilhaMargarida Fardilha
Margarida Fardilha
Protein phosphorylation is a key mechanism by which normal and cancer cells regulate their main transduction pathways. Protein kinases and phosphatases are precisely orchestrated to achieve the (de)phosphorylation of candidate proteins. Indeed, cellular health is dependent on the fine‐tune of phosphorylation systems, which when deregulated lead to cancer. Transforming growth factor beta (TGF‐β) pathway involvement in the genesis of prostate cancer has long been established. Many of its members were shown to be hypo‐ or hyperphosphorylated during the process of malignancy. A major phosphatase that is responsible for the vast majority of the serine/threonine dephosphorylation is the phosphoprotein phosphatase 1 (PPP1). PPP1 has been associated with the dephosphorylation of several proteins involved in the TGF‐β cascade. This review will discuss the role of PPP1 in the regulation of several TGF‐β signalling members and how the subversion of this pathway is related to prostate cancer development. Furthermore, current challenges on the protein phosphatases field as new targets to cancer therapy will be addressed.

24 February 2015 in Expert Review of Proteomics
Verified
Journal Article
Closed access
JSJoana Silva
Joana Silva
MFMaria João Freitas
Maria João Freitas
JFJuliana Felgueiras
Juliana Felgueiras
Margarida FardilhaMargarida Fardilha
Margarida Fardilha
Since the description of the yeast two-hybrid (Y2H) method, it has become more and more evident that it is the most commonly used method to identify protein-protein interactions (PPIs). The improvements in the original Y2H methodology in parallel with the idea that PPIs are promising drug targets, offer an excellent opportunity to apply the principles of this molecular biology technique to the pharmaceutical field. Additionally, the theoretical developments in the networks field make PPI networks very useful frameworks that facilitate many discoveries in biomedicine. This review highlights the relevance of Y2H in the determination of PPIs, specifically phosphoprotein phosphatase 1 interactions, and its possible outcomes in pharmaceutical research.


3 March 2017 in Photochemical & Photobiological Sciences
Verified
Journal Article
Closed access
PDF file
EMElisabete Maciel
Elisabete Maciel
JFJuliana Felgueiras
Juliana Felgueiras
Eduarda M. P. SilvaEduarda M. P. Silva
Eduarda M. P. Silva
FRFernando Ricardo
Fernando Ricardo
Ana Sofia Pereira MoreiraAna Sofia Pereira Moreira
Ana Sofia Pereira Moreira
MDM Rosario Domingues
M Rosario Domingues
Extensive exposure to UVA is thought to increase the risk of malignancy and the progression of melanoma, the most serious type of skin cancer. It is well known that alterations in lipid metabolism represent an early event in carcinogenesis, but the impact of UVA exposure on the lipid composition of cancer cells is still largely unknown. In this study we aimed at investigating lipid remodeling in human melanoma cells in response to UVA exposure. After UVA irradiation, lipid extracts were either immediately collected from SK-MEL-28 cells or collected after a recovery period of 2 h or 24 h. The lipid profiles for each event were determined by liquid chromatography or gas chromatography coupled to mass spectrometry. UVA exposure led to major alterations in both fatty acids (FA) and phospholipid profiles. An increase of monounsaturated FA (MUFA) and FA18:0, as well as a decrease of FA16:0, were observed 24 h after irradiation. Moreover, phosphatidylcholine (PC) decreased and phosphatidylinositol (PI) increased after UVA exposure. Molecular alterations in the PC, lysoPC, PI, phosphatidylethanolamine (PE), ether-linked PE and phosphatidylglycerol (PG) profiles were also observed. The absence of cleaved caspase-3 after 2 h and 24 h of re-incubation is correlated with impairment of apoptosis. Overall, these data showed changes in membrane lipids, which may be associated with lipogenesis after UVA exposure which, in turn, is usually a determinant for cell survival.

9 June 2017 in Journal of Coordination Chemistry
Verified
Journal Article
Closed access
Magda Carvalho HenriquesMagda Carvalho Henriques
Magda Carvalho Henriques
Maria Amparo FaustinoMaria Amparo Faustino
Maria Amparo Faustino
Artur M. S. SilvaArtur M. S. Silva
Artur M. S. Silva
JFJuliana Felgueiras
Juliana Felgueiras
Margarida FardilhaMargarida Fardilha
Margarida Fardilha
Susana BragaSusana Braga
Susana Braga
The coordination of ruthenium(II) complexes to anionic oxygen-based donors are very rare. This study describes a simple, one-pot method for obtaining [ruthenium(II)(trithiacyclononane)(curcumin)(S-DMSO)]Cl (1) in 37% yield. The structural characterization of complex 1 by elemental analysis, FT-IR, 1-D and 2-D NMR, ESI+-MS as well as UV–vis and fluorescence spectroscopies are presented. The DNA-melting temperature (Tm) assay shows that salmon sperm DNA (smDNA) in the presence of complex 1 has a higher melting temperature, with ΔTm = 7.4 °C, while in the presence of curcumin the melting temperature remains unaltered. The in vitro cytotoxic activities of curcumin and complex 1 were investigated using the tumor human prostate cell line, PC-3, and the healthy cell line, PNT-2. Complex 1 is innocuous toward normal prostate epithelial cells and, whereas curcumin is toxic, with inhibition rates of ca. 35 and 65% at 50 and 80 μM, respectively. On the tumor cell line PC-3, complex 1 did not cause viability changes, whereas curcumin exhibited dose-dependent inhibition, with ca. 73% inhibition at the highest concentration tested, i.e. 80 μM. This study suggests that coordination with the trithiacyclononane ruthenium(II) scaffold stabilizes the photochemical properties of curcumin and strongly changes its biologic activity.